4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-033914
Chief Executive Officer sold 4,800 shares at an average $14.91 ($71,568)
From the SEC's structured data for this filing
Trades in this filing
Ciechanover Isaac E. · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-05-17 | Sale : show line 1 in the form | −2,400 | $14.88 | $35,712 | 465,378 | I |
| 2017-05-18 | Sale : show line 2 in the form | −2,400 | $14.94 | $35,856 | 462,978 | I |
| Open-market sales · 4,800 sh · avg $14.91 · $71,568 | ||||||
Loading xslF345X03/doc4.xml…